Article: Retinoblastoma: ten years experience at kanti children's hospital
| creativeworkseries.issn | JNMA Print ISSN: 0028-2715; Online ISSN: 1815-672X | |
| dc.contributor.author | Sah, Kailash Prasad | |
| dc.contributor.author | Saiju, Rohit | |
| dc.contributor.author | Roy, Pankaj | |
| dc.contributor.author | Kafle, Sonali | |
| dc.creator.affiliation | Kanti Children’s Hospital, Nepal. | |
| dc.creator.affiliation | Tilganga Eye Hospital, Kathmandu, Nepal. | |
| dc.creator.affiliation | Kanti Children’s Hospital, Nepal. | |
| dc.creator.affiliation | Kanti Children’s Hospital, Nepal. | |
| dc.date.accessioned | 2026-10-12T06:29:55Z | |
| dc.date.available | 2026-10-12T06:29:55Z | |
| dc.date.issued | 2013 | |
| dc.description.abstract | Abstract Introduction: Retinoblastoma is a malignant tumor of the embryonic neural retina. It is the most common intraocular tumor of childhood. It is a disease of early childhood with 80% cases diagnosed before the age of 4 years. The median age at diagnosis is 2 years. Bilateral cases are diagnosed earlier (median at 12 months and unilateral median age at 24 months). The incidence of retinoblastoma is approximately 1 in 15000-18000 live births in developed countries. The aim of the research is to study the clinical pathological features, treatment and survival of children with retinoblastoma over ten years. Methods: A retrospective hospital based study was conducted from March 1998 to February 2008. Gender, age, clinical presentation, pathology reports, treatment, follow –up and outcome were recorded at time of diagnosis. Results: A total of 42 children with retinoblastoma (85.7 % unilateral, 14.3% bilateral), with 50% having optic nerve involvement were studied. The most common presenting signs were extraoccular (28.6%), proptosis (23.8%), leukoria (23.8%), phthisis bulbi (16.7%), and strabismus (7.1%). The age at presentation ranged from 6-120 months with mean age of 46.6 months. The male to female ratio was 1.1:1.Two-thirds presented between 2-5 yrs, followed by 12-24 months (23.8%). Majority of children had poorly differentiated retinoblastoma (62 %), followed by well differentiated (28.6%), and moderately differentiated (9.5%). CEV based protocol used to treat, and over-all 10 yrs survival was 23.8 %, death 19 %, and lost to follow-up or left against medical advice 57.2%. Conclusions: Despite severe resource limitation, pediatric oncology unit has been successfully treating retinoblastoma with the success rate of 23.8%. Keywords: Chemotherapy; Outcome; Remission; Retinoblastoma. | |
| dc.identifier.doi | https://doi.org/10.31729/jnma.2429 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14572/8100 | |
| dc.language.iso | en_US | |
| dc.publisher | Nepal Medical Association | |
| dc.subject | Chemotherapy | |
| dc.subject | Outcome | |
| dc.subject | Remission | |
| dc.subject | Retinoblastoma | |
| dc.title | Retinoblastoma: ten years experience at kanti children's hospital | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.article.type | Original Article | |
| oaire.citation.endPage | 579 | |
| oaire.citation.startPage | 576 | |
| relation.isJournalIssueOfPublication | 8d841c1c-a325-4c44-832d-306937ec270c | |
| relation.isJournalIssueOfPublication.latestForDiscovery | 8d841c1c-a325-4c44-832d-306937ec270c | |
| relation.isJournalOfPublication | e6e146a0-0ece-4aba-aa0a-6ccfbd10a12a |